Sara Adia
About Sara Adia
Sara Adia is an API Manager at Dechra Pharmaceuticals Plc in Northwich, Cheshire, United Kingdom, with over 18 years of experience in the pharmaceutical industry. She holds a Bachelor of Science in Chemistry from Queen Mary University of London and has previously worked in various roles at Shell, Mylan, and Merck Group.
Work at Dechra Pharmaceuticals
Sara Adia has been serving as the API Manager at Dechra Pharmaceuticals Plc since 2018. In this role, she is responsible for overseeing the management of Active Pharmaceutical Ingredients (APIs) within the organization. Based in Northwich, Cheshire, United Kingdom, her position involves coordinating logistics and purchasing related to API management, contributing to the company's focus on veterinary pharmaceuticals.
Education and Expertise
Sara Adia holds a Bachelor of Science degree in Chemistry from Queen Mary University of London, where she studied from 1991 to 1994. Additionally, she pursued further studies in Chemistry at the University of Liverpool from 1995 to 1997. With over 18 years of experience in the pharmaceutical industry, she possesses strong technical knowledge in managing APIs, logistics, and purchasing, particularly in both human and veterinary pharmaceuticals.
Background in the Pharmaceutical Industry
Sara Adia has a diverse background in the pharmaceutical industry, having worked in various roles across multiple organizations. She began her career as a Scientist at Shell in The Hague, Netherlands, from 1994 to 1998. She then joined Merck Group as an API Project Manager from 2001 to 2008, before moving to Mylan, where she held positions as Director of API Sourcing and later as Head of API Sourcing for Europe and Asia-Pacific from 2008 to 2015.
Professional Skills
Sara Adia is recognized for her problem-solving abilities and possesses excellent communication and leadership skills. Her extensive experience in managing APIs and logistics for multi-site manufacturing organizations has equipped her with a comprehensive understanding of the pharmaceutical supply chain. This expertise is complemented by her strong technical knowledge of the industry.